Eric Dube (He/Him)
About Eric Dube (He/Him)
Eric Dube serves as the CEO of Travere Therapeutics since 2019 and has a background in leadership roles at GlaxoSmithKline. He advocates for a culture of belonging and focuses on health equity, driven by his personal experiences as a rare cancer survivor.
Work at Travere Therapeutics
Eric Dube has served as the CEO of Travere Therapeutics since 2019, contributing to the company's mission in the life sciences sector. Under his leadership, the organization focuses on developing innovative therapies for rare diseases. Dube emphasizes a culture of belonging within the company, advocating for an environment where employees can express their authentic selves. His role involves strategic decision-making and guiding the company towards fulfilling its objectives in patient care.
Previous Experience at GSK
Before joining Travere Therapeutics, Eric Dube held several significant positions at GlaxoSmithKline (GSK). He served as the Senior Vice President and Head of the Global Respiratory Franchise from 2015 to 2017 in London. Prior to this, he was the Senior Vice President of Strategy, Planning & Operations for US Pharmaceuticals from 2011 to 2013 in the Greater Philadelphia Area. Dube also led the Oncology Business Unit as Vice President from 2008 to 2011, gaining extensive experience in pharmaceutical management.
Education and Expertise
Eric Dube holds a PhD in Developmental & Social Psychology from Cornell University, which he completed from 1995 to 1999. He also earned a Bachelor of Science in Biopsychology from Santa Clara University between 1991 and 1994. Additionally, he briefly studied Finance and Financial Management Services at Harvard Business School in 2012. This diverse educational background supports his expertise in both psychology and business, enhancing his leadership in the life sciences industry.
Commitment to Health Equity
Eric Dube's personal experiences, including his diagnosis as a rare cancer survivor, have shaped his commitment to health equity. He advocates for ensuring that health equity is central to the life sciences industry, driven by a desire to provide hope and representation for individuals who may feel marginalized within the healthcare system. His understanding of health equity was further influenced by his experiences during the AIDS epidemic in San Francisco.
Role at Reneo Pharmaceuticals
In addition to his role at Travere Therapeutics, Eric Dube has served as an Independent Director at Reneo Pharmaceuticals since 2021. This position allows him to contribute to the strategic direction and governance of the company, focusing on the development of therapies for rare diseases. His involvement with Reneo Pharmaceuticals complements his leadership experience in the life sciences sector.